HMGB1 Promotes the Differentiation of Th17 via Up-Regulating TLR2 and IL-23 of CD14+ Monocytes from Patients with Rheumatoid Arthritis

Scandinavian Journal of Immunology

Volumn 76, Issue 5, 2012, Pages 483-490

  He, Z ^a,b   Shotorbani, S S ^a   Jiao, Z ^c   Su, Z ^a   Tong, J ^a   Liu, Y ^a   Shen, P ^a   Ma, J ^a   Gao, J ^a   Wang, T ^a   Xia, S ^a   Shao, Q ^a   Wang, S ^a   Xu, H ^a  

^a JIANGSU UNIVERSITY   (China)

^b Second Traditional Chinese Medicine Hospital of Zhengzhou   (China)

^c AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 6; TOLL LIKE RECEPTOR 2;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HUMAN; LYMPHOCYTE DIFFERENTIATION; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; TH17 CELL; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD14; ARTHRITIS, RHEUMATOID; CELL DIFFERENTIATION; CELL POLARITY; CELLS, CULTURED; FEMALE; HMGB1 PROTEIN; HUMANS; INTERLEUKIN-23; MALE; MIDDLE AGED; MONOCYTES; NF-KAPPA B; TH17 CELLS; TOLL-LIKE RECEPTOR 2;

EID: 84867412116     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2012.02759.x     Document Type: Article

References (27)

1. Hreggvidsdóttir HS, Lundberg AM, Aveberger AC et al. HMGB1-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor. Mol Med 2011;69:631-7.
2. Li T, Zuo X, Zhou YJ et al. The vagus nerve and nicotinic receptors involve inhibition of HMGB1 release and early pro-inflammatory cytokines function in collagen-induced arthritis. Clin Immunol 2010;30:213-20.
3. Brentano F, Kyburz D, Gay S. Toll-like receptors and rheumatoid arthritis. Methods Mol Biol 2009;517:329-43.
4. Kokkola R, Sundberg E, Ulfgren AK et al. High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. Arthritis Rheum 2002;46:2598-603.
5. Goldstein RS, Bruchfeld A, Yang L et al. Cholinergic anti-inflammatory pathway activity and high mobility group box-1 (HMGB1) serum levels in patients with rheumatoid arthritis. Mol Med 2007;13:210-5.
6. Gardella S, Andrei C, Ferrera D et al. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-media- ted secretory pathway. EMBO Rep 2002;3:995-1001.
7. Osamu T, Shintaro S, Takao H et al. Role of toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 2002;169:10-4.
8. Luis BB, Meriem B-A, Hélène Q. Evolutionary dynamics of human toll-like receptors and their different contributions to host defense. J Plos Genet 2009;75:9-17.
9. Sims GP, Rowe DC, Rietdijk ST et al. HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 2010;62:367-88.
10. Shahrara S, Huang Q, Mandelin AM 2nd et al. TH-17 cells in rheumatoid arthritis. Arthritis Res Ther 2008;10:R93.
11. Smeekens SP, van de Veerdonk FL, Joosten LA et al. The classical CD14(++)CD16(-) monocytes, but not the patrolling CD14(+)CD16 (+) monocytes, promote Th17 responses to Candida albicans. Eur J Immunol 2011;10:1002-6.
12. Arnett FC, Edworty S. The American rheumatoid association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
13. Abdollahi-Roodsaz S, van de Loo FA, van den Berg WB. Trapped in a vicious loop: toll-like receptors sustain the spontaneous cytokine production by rheumatoid synovium. Arthritis Res Ther 2011;13:105-7.
14. Huang QQ, Sobkoviak R, Jockheck-Clark AR et al. Heat shock protein 96 is elevated in rheumatoid arthritis and activates macrophages primarily via TLR2 signaling. J Immunol 2009;182:4965-73.
15. He C, Lai P, Weng J et al. Toll-like receptor 2-mediated NF-κB inflammatory responses in dry eye associated with cGVHD. Mol Vis 2011;17:2605-11.
16. Volz HC, Kaya Z, Katus HA et al. The role of HMGB1/RAGE in inflammatory cardiomyopathy. Semin Thromb Hemost 2010;36:185-94.
17. Curtin JF, Liu N, Candolfi M et al. HMGB1 mediates endogenous TLR2 activation and brain tumor regression. PLoS Med 2009;6:83-104.
18. Yang H, Hreggvidsdottir HS, Palmblad K et al. A critical cysteine is required for HMGB1 binding to toll-like receptor 4 and activation of macrophage cytokine release. PNAS 2010;107:11942-7.
19. Akirav EM, Preston-Hurlburt P, Garyu J et al. RAGE expression in human T cells: a link between environmental factors and adaptive immune responses. PLoS ONE 2012;7:e34698.
20. Wondimu Z, Santodomingo-Garzon T, Le T et al. Protective role of interleukin-17 in murine NKT cell-driven acute experimental hepatitis. Am J Pathol 2010;177:2334-46.
21. Song C, Luo L, Lei Z et al. IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma. J Immunol 2008;181:6117-24.
22. Shahrara S, Pickens SR, Mandelin AM 2nd et al. IL-17-mediated monocyte migration occurs partially through CC chemokine ligand 2/monocyte chemoattractant protein-1 induction. J Immunol 2010;184:4479-87.
23. Shi Y, Sandoghchian SS, Su Z et al. Enhanced HMGB1 expression may contribute to Th17 cells activation in rheumatoid arthritis. Clin Dev Immunol 2012;2012:295081.
24. Su Z, Sun C, Zhou C et al. HMGB1 blockade attenuates experimental autoimmune myocarditis and suppresses Th17-cell expansion. Eur J Immunol 2011;41:3586-95.
25. Paradowska A, Maśliński W, Grzybowska-Kowalczyk A et al. The function of interleukin 17 in the pathogenesis of rheumatoid arthritis. Archivum Immunologiae ET Therapiae Experimentalis 2011;5:329-34.
26. Ziolkowska M, Kloc A, Luszczykiewicz G et al. High levels of IL-17 in rheumatoid arthritis patients. J Immunol 2010;164:2832-8.
27. Park JS, Arcaroli J, Yum HK et al. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol Cell Physiol 2003;284:C870-9.